MSH|^~\&|LAB|ARH|||201911151411||ORU^R01|4106541|D|2.3|||AL|NE PID|1||AB00008248|AB8147|LABTEST^HFE^||20010101|F||||||||||AB000498/19|9875034351 OBR|1|35217^LAB|00027054^1511:C00005R^LAB^151119:C5^35217|220.5080^HFE CD^Hemochromatosis-Conf Diagnosis^^^XXX-1182||201911151403|201911151403|||||||201911151403||||||||||LAB|I|||| OBR|2|35217^LAB|00027054^1511:C00005R^LAB^151119:C5^35217|520.4200^IRON^Iron Studies Profile^^^50190-8||201911151403|201911151403|||||||201911151403||||||||||LAB|F|||| OBX|1|ST|520.4300^FE^Iron^^14798-3^14798-3|1|30^^Y|umol/L|9-30|N||A^S|F|||201911151411 OBX|2|ST|520.4500^TIBC^Total Iron Binding Capacity^^14800-7^14800-7|1|40^^Y|umol/L|45-70|L||A^S|F|||201911151411 OBX|3|ST|520.4600^TRFSAT^Transferrin Saturation^^6796-7^14801-5|1|0.75^^Y||0.15-0.55|H||A^S|F|||201911151411 NTE|1||Markedly elevated transferrin saturation. Follow up and NTE|2||management as per BCMA/MSP Iron Overload protocol.  MSH|^~\&|LAB|ARH|||201911151412||ORU^R01|4106542|D|2.3|||AL|NE PID|1||AB00008248|AB8147|LABTEST^HFE^||20010101|F||||||||||AB000498/19|9875034351 OBR|1|35217^LAB|00027054^1511:C00005R^LAB^151119:C5^35217|220.5080^HFE CD^Hemochromatosis-Conf Diagnosis^^^XXX-1182||201911151403|201911151403|||||||201911151403||||||||||LAB|F|||| OBX|1|ST|520.4700^FER^Ferritin^^2276-4^2276-4|1|350^^Y|ug/L|15-200|H||A^S|F|||201911151412 OBR|2|35217^LAB|00027054^1511:C00005R^LAB^151119:C5^35217|520.4200^IRON^Iron Studies Profile^^^50190-8||201911151403|201911151403|||||||201911151403||||||||||LAB|F|||| OBX|1|ST|520.4300^FE^Iron^^14798-3^14798-3|1|30^^Y|umol/L|9-30|N||A^S|F|||201911151411 OBX|2|ST|520.4500^TIBC^Total Iron Binding Capacity^^14800-7^14800-7|1|40^^Y|umol/L|45-70|L||A^S|F|||201911151411 OBX|3|ST|520.4600^TRFSAT^Transferrin Saturation^^6796-7^14801-5|1|0.75^^Y||0.15-0.55|H||A^S|C|||201911151412 NTE|1||Hyperferritinemia and elevated transferrin saturation index: NTE|2||Patient meets criteria for HFE genetic testing as specified NTE|3||in the current BC Guidelines. NTE|4|| **** CORRECTED RESULT **** NTE|5|| --- 15/11/19 1412 --- NTE|6|| TRFSAT previously reported as: 0.75 H NTE|7|| NTE|8|| NTE|9||Markedly elevated transferrin saturation. Follow up and NTE|10||management as per BCMA/MSP Iron Overload protocol. OBR|3|35217^LAB|00027054^1511:C00005R^LAB^151119:C5^35217|520.4720^HFE HH^Hemochromatosis^^^XXX-1182||201911151403|201911151403|||||||201911151403||||||||||LAB|I||||